Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BCMA antibodies and use of same to treat cancer and immunological disorders

BCMA antibodies and use of same to treat cancer and immunological disorders

US Patent 11078291 · Granted Aug 3, 2021

Estimated economic value: $138,536,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αVβ6 antibodies and antibody-drug conjugates2025
Anti-αVβ6 antibodies and antibody-drug conjugates2025
CD47 antibodies and uses thereof for treating cancer2024
CD47 antibodies and uses thereof for treating cancer2024
Antibody libraries2024
Cysteine mutated antibodies for conjugation2024
Anti-AVB6 antibodies and antibody-drug conjugates2023
Anti-AVB6 antibodies and antibody-drug conjugates2023
Glypican 3 antibodies and conjugates thereof2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023